RXO (NYSE: RXO) reported Q1 EPS of ($0.09), $0.15 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $1.43 billion, versus $0 reported last year.

Second-Quarter Outlook

RXO expects second-quarter 2026 adjusted EBITDA to be between $27 million and $37 million.

For earnings history and earnings-related data on RXO (RXO) click here.